Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V W Johnson

Showing results (31-40 of 163) with videos related to

Pageof 17
Sort By:
Journal of Alzheimer'S Disease : JAD|August 18, 2020
Presenilin 1 Regulates Membrane Homeostatic Pathways that are Dysregulated in Alzheimer's DiseaseCarol A Deaton, Gail V W Johnson
Neuroscience Letters|June 21, 2005
14-3-3Zeta does not increase GSK3beta-mediated tau phosphorylation in cell culture modelsTori A Matthews, Gail V W Johnson
Journal of Neurochemistry|December 24, 2003
Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubulesJae-Hyeon Cho, Gail V W Johnson
Biochimica Et Biophysica Acta|December 24, 2004
Tau phosphorylation: physiological and pathological consequencesWilliam H Stoothoff, Gail V W Johnson
Journal of Cell Science|November 13, 2004
Tau phosphorylation in neuronal cell function and dysfunctionGail V W Johnson, William H Stoothoff
Trends in Biochemical Sciences|April 23, 2004
The glamour and gloom of glycogen synthase kinase-3Richard S Jope, Gail V W Johnson
Journal of Bioenergetics and Biomembranes|June 18, 2010
The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington diseaseYoungnam N Jin, Gail V W Johnson
Expert Opinion on Therapeutic Targets|October 5, 2021
Transglutaminase 2 as a therapeutic target for neurological conditionsJeffrey W Keillor, Gail V W Johnson
Neuroscience Letters|April 19, 2015
Tau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neuronsSusanne P Pallo, Gail V W Johnson
Brain Research Bulletin|July 23, 2009
Role of mitochondrial dysfunction in the pathogenesis of Huntington's diseaseRodrigo A Quintanilla, Gail V W Johnson
Pageof 17

Showing results (31-40 of 163) with videos related to

Sort By:
Pageof 17
Journal of Alzheimer'S Disease : JAD|August 18, 2020
Presenilin 1 Regulates Membrane Homeostatic Pathways that are Dysregulated in Alzheimer's DiseaseCarol A Deaton, Gail V W Johnson
Neuroscience Letters|June 21, 2005
14-3-3Zeta does not increase GSK3beta-mediated tau phosphorylation in cell culture modelsTori A Matthews, Gail V W Johnson
Journal of Neurochemistry|December 24, 2003
Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubulesJae-Hyeon Cho, Gail V W Johnson
Biochimica Et Biophysica Acta|December 24, 2004
Tau phosphorylation: physiological and pathological consequencesWilliam H Stoothoff, Gail V W Johnson
Journal of Cell Science|November 13, 2004
Tau phosphorylation in neuronal cell function and dysfunctionGail V W Johnson, William H Stoothoff
Trends in Biochemical Sciences|April 23, 2004
The glamour and gloom of glycogen synthase kinase-3Richard S Jope, Gail V W Johnson
Journal of Bioenergetics and Biomembranes|June 18, 2010
The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington diseaseYoungnam N Jin, Gail V W Johnson
Expert Opinion on Therapeutic Targets|October 5, 2021
Transglutaminase 2 as a therapeutic target for neurological conditionsJeffrey W Keillor, Gail V W Johnson
Neuroscience Letters|April 19, 2015
Tau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neuronsSusanne P Pallo, Gail V W Johnson
Brain Research Bulletin|July 23, 2009
Role of mitochondrial dysfunction in the pathogenesis of Huntington's diseaseRodrigo A Quintanilla, Gail V W Johnson
Pageof 17